ClinicalTrials.gg
Sign In

DrugBiological

JS007 clinical trials

Also written JS007.

studies test it
4
open now
3
in phase 3
1
first study started
2021

Keep track of what changes. Save the JS007 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Development codes

JS007
4

Studies by the year they started

4 studies that test it; most in 2021 (1)

Studies that test JS007, by start year
YearStudies
20211
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
2
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it.

Carcinoma, Hepatocellular
2
Pancreatic Neoplasms
1
Neoplasms
1

Who runs them

Industry 0 · Other 4

Shanghai Junshi Bioscience Co., Ltd. (3) · Fudan University (1)

Often tested with

Tested in the same studies.

Anti-PD-1/Anti-VEGF Bispecific Antibody JS207 (1) · Tifcemalimab (1) · Anti-DKK1 Monoclonal Antibody JS015 (1) · Irinotecan sucrosofate (1) · Fluorouracil (1) · Leucovorin (1) · Albumin-Bound Paclitaxel (1) · Paclitaxel (1)

Studies

Open first, then newest update. How each study uses JS007 is read from its arms, and is right about nine times in ten.

Testing it · 4